v3.26.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 5,781,128 $ 4,547,530
Accounts receivable, net 1,092,535 865,080
Inventories, net 807,922 608,227
Prepaid expenses and other current assets 249,654 212,752
Total current assets 7,931,239 6,233,589
Property, plant and equipment, net 1,647,231 1,641,678
Operating lease right-of-use assets 150,008 148,184
Other non-current assets 147,447 165,122
Total non-current assets 1,944,686 1,954,984
Total assets 9,875,925 8,188,573
Current liabilities:    
Accounts payable 496,879 479,035
Accrued expenses and other payables 1,342,646 1,109,120
Income tax payable 14,801 41,625
Operating lease liabilities, current portion 24,462 20,698
Research and development cost share liability, current portion 0 64,345
Sale of future royalty liability, current portion 106,274 56,714
Short-term debt 248,861 57,293
Total current liabilities 2,233,923 1,828,830
Non-current liabilities:    
Long-term debt 825,220 961,913
Sale of future royalty liability, non-current portion 806,307 850,242
Operating lease liabilities, non-current portion 50,223 52,940
Deferred tax liabilities 60,085 53,209
Other long-term liabilities 79,773 80,245
Total non-current liabilities 1,821,608 1,998,549
Total liabilities 4,055,531 3,827,379
Commitments and contingencies
Shareholders’ equity:    
Number Of Authorized Shares, Not Disclosed true  
Ordinary shares, $0.0001 par value per share; 1,541,841,971 and 1,540,975,898 shares issued and 1,483,318,035 and 1,441,075,618 shares outstanding as of September 30, 2026 and December 31, 2025, respectively $ 148 144
Additional paid-in capital 13,297,690 12,759,137
Accumulated other comprehensive loss (6,611) (78,184)
Accumulated deficit (7,470,833) (8,319,903)
Total shareholders’ equity 5,820,394 4,361,194
Total liabilities and shareholders’ equity $ 9,875,925 $ 8,188,573